{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-090060","form_type":"8-K","ticker":"VUZI","cik":"0001463972","company_name":"Vuzix Corp","filed_at":"2024-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.124777+00:00","generated_at":"2026-05-31T08:59:39.734198+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Vuzix Q2 revenue down 77% to $1.1M, net loss $40.6M on $30.1M impairment charge","bullets":["Total revenues $1.1M, down 77% YoY from $4.7M; product sales fell to $601K from $4.4M.","Gross loss of $333K vs gross profit of $972K in Q2 2023; gross margin -30%.","Non-cash impairment charge of $30.1M on Atomistic license write-off, driving net loss to $40.6M ($0.62/share).","Cash net loss (non-GAAP) $5.9M vs $4.5M; cash and equivalents $9.9M, working capital $22.1M.","Company reduced annual cost structure by $8M vs 2023; expects H2 revenue improvement from enterprise and defense."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-090060","json":"https://secwatch.observer/filing/0001104659-24-090060.json","markdown":"https://secwatch.observer/filing/0001104659-24-090060.md","text":"https://secwatch.observer/filing/0001104659-24-090060.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1463972/000110465924090060/0001104659-24-090060-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1463972/000110465924090060/tm2421809d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:59:39.734198+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}